Radicle Science is kicking off the Fall season with new team members & study launches!
Radicle Science Announces XPRIZE Foundation and Singularity University Founder Peter H. Diamandis MD as Chair of Advisory Board
Peter H. Diamandis, MD joined as Chair of the Radicle Science Advisory Board in October 2021. Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Diamandis is the founder and Executive Chair of the XPRIZE Foundation, which leads the world in running large-scale competitions to develop technologies that benefit humanity. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world’s leaders on exponentially growing technologies.
“The co-founders of Radicle Science, Pelin and Jeff, along with the team who’s joined their movement, are brilliant, passionate and inspiring. Their audacious vision to reimagine traditional pharma efficacy trials promises to rapidly and accurately determine which nutraceuticals and natural molecules actually work for which conditions,” said Diamandis. “Radicle Science has the potential to help dematerialize, demonetize and democratize clinical trials, and unlock a future of meaningful and abundant health products directly accessible by all.”
Peter H. Diamandis, MD
Founder and Executive Chair of the XPRIZE Foundation
Radicle Science also announced a new CTO, Sheldon Borkin, PhD, who joined in September 2021. Borkin has been a technical and business leader at numerous start-ups and contributed his expertise to multiple IPOs. While at WebMD from startup through IPO to $1B/year revenue, he held multiple senior technical & leadership roles, including Chief Security Officer.
Radicle Real World Sleep study series launches
“We’ve experienced extraordinary growth across all dimensions of our business over the past year.“ said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science.
This week, Radicle Science also marks the launch of Radicle Real World Sleep, a series of first of its kind real-world evidence (RWE) studies focused exclusively on the effectiveness of cannabinoid products on sleep. These four-week, randomized, controlled trials (RCT) of orally ingestible cannabinoid products will generate RWE insights in areas including user’s behavior and characteristics, health status, dosing, consumption patterns, effectiveness for various health outcomes, onset and duration of effect, side effects, and possible predictors/modifiers of treatment response.
Brands participating in the studies include Cannafloria Wellness, CÜRE CBD Wellness, Mendi, Our Treaty, RealSleep, Straight Hemp, Trokie, and Vitaldiol.